Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorHacettepe University
About this trial
Health literacy is important for controlling disease progression and living a healthy life with illness. High health literacy is associated with higher cognitive performance and lower health-related quality of life. Physical, psychological, and social impairments are seen in chronic obstructive pulmonary disease (COPD). Studies investigating the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD are limited. Therefore, the aim of this study was to compare individuals with COPD with healthy individuals in terms of health literacy, functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living and to investigate the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being over 40 years old,
Diagnosed with COPD and being clinically stable,
Being able to cooperate with the tests to be performed,
Not having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
Disqualifiers
Being in an acute exacerbation period,
Having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
Not being willing to participate in the study.
Being willing to participate in the study and being over 40 years old
Trial population
Individuals with COPD and Healthy Controls
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
144 Participants
are divided into 2 treatment groupsGroup A: COPD1 intervention
Group B: Healthy Individuals1 intervention
Trial outcomes
Primary outcomes
1
Functional capacity
Functional capacity assessment using self-paced 6-minute walk test.
Time frame
1st day2
Health literacy
Test of Functional Health Literacy in Adults will be used to evaluate health literacy. The TOFHLA is scored on a scale of 0 to 100 and higher scores indicate higher health literacy.
Time frame
1st day3
Health literacy
The Rapid Estimate of Adult Literacy in Medicine questionnaires will be performed. A score of 59 or less is defined as indicating low health literacy and a score of 60 or more indicates adequate health literacy.
Time frame
1st day4
Cognitive function
Montreal Cognitive Assessment will be used to evaluate cognitive function. The Montreal Cognitive Assessment scores range between 0 and 30. A score of 26 or over is considered to be normal.
Time frame
1st daySecondary outcomes
1
Forced vital capacity
Pulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.
Time frame
1st day2
Forced expiratory volume in one second
Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.
Time frame
1st day3
forced expiratory volume in one second/forced vital capacity ratio
Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second/forced vital capacity ratio will be recorded.
Time frame
1st day4
Peak expiratory flow
Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.
Time frame
1st daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov